Intravenous ketamine for the treatment of refractory status epilepticus: A retrospective multicenter study
Abstract
To examine patterns of use, efficacy, and safety of intravenous ketamine for the treatment of refractory status epilepticus (RSE).
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Jun 12, 2013
- Source ID
- 10.1111/epi.12247
Entities
People
- Ali Al‐otaibi
- Asma Zakaria
- Barnett R. Nathan
- Benjamin Legros
- Blathnaid M. Mccoy
- Brandon Foreman
- Cecil D. Hahn
- Giridhar P. Kalamangalam
- Howard P. Goodkin
- Ivan Sánchez Fernández
- James N. Brenton
- Jan Claassen
- Jerzy P Szaflarski
- Lawrence J. Hirsch
- Lilith M. Judd
- Lucy Mendoza
- Nicolas Gaspard
- Ronan Kilbride
- Sophie Samuel
- Suzette M. Laroche
- Tobias Loddenkemper
Organizations
- American Academy of Neurology
- Boston Children's Hospital
- Canadian Institutes of Health Research
- Columbia University
- Emory University
- Fundación Alfonso Martín Escudero
- Hospital for Sick Children
- Lundbeck
- Massachusetts General Hospital
- Office of Small Business Innovation Research and Small Business Technology Transfer Programs
- Physicians' Services Incorporated Foundation
- UCB
- University of Cincinnati
- University of Texas at Austin
- University of Virginia
- Université Libre de Bruxelles
- Yale University